MRVI: Maravai LifeSciences Holdings, Inc. Class A Common Stock Company Profile & Statistics

Maravai LifeSciences Holdings, Inc. Class A Common Stock Profile

About

Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.

Info & Links

CEO

William E. Martin, III

Headquarters

10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

570

Maravai LifeSciences Holdings, Inc. Class A Common Stock Statistics

Valuation Measures

Market Capitalization²

412.91M

Enterprise Value

468.41M

Enterprise Value/EBITDA(ttm)

-9.64

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

3.84

Price to Book(mrq)

1.58

Price to Cash(ytd)

4.68

Profitability

Gross Margin(ttm)

28.73%

Operating Margin(ttm)

-58.46%

Profit Margin(ttm)

-84.75%

Return on Equity(ttm)

-21.42%

Return on Invested Capital(ttm)

-34.98%

Return on Assets(ttm)

-11.78%

Income Statement

Revenue(ttm)

219.83M

Revenue Per Share(ttm)

0.86

Gross Profit(ttm)

67.12M

EBITDA(ttm)³

-48.60M

Net Income Available to Common(ttm)

-192.51M

Diluted EPS(ttm)

-0.84

Share Statistics

Beta (5Y Monthly)

0.34

52-Week Change

-64.20%

S&P 500 52-Week Change

12.23%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

255.36M

Dividend Yield

0.00%

Float⁴

249.97M

% Held by Insiders

2.11%

% Held by Institutions

50.25%

Balance Sheet

Total Cash(mrq)

269.91M

Total Cash Per Share(mrq)

1.06

Total Debt(mrq)

325.40M

Total Debt/Equity(mrq)

69.53%

Current Ratio(mrq)

5.16%

Quick Ratio(mrq)

4.49%

Book Value Per Share(mrq)

1.83

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.14

Free Cash Flow(ytd)

-27.76M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

MRVI

Maravai LifeSciences Holdings, Inc. Class A Common Stock